These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20815370)

  • 1. Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin.
    Casar Z; Steinbücher M; Kosmrlj J
    J Org Chem; 2010 Oct; 75(19):6681-4. PubMed ID: 20815370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly stereoselective hydrogenations--as key-steps in the total synthesis of statins.
    Andrushko N; Andrushko V; Tararov V; Korostylev A; König G; Börner A
    Chirality; 2010 May; 22(5):534-41. PubMed ID: 19899159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates.
    Greenberg WA; Varvak A; Hanson SR; Wong K; Huang H; Chen P; Burk MJ
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5788-93. PubMed ID: 15069189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of alpha-fluoro- and alpha,alpha-difluoro-benzenemethanesulfonamides: new inhibitors of carbonic anhydrase.
    Blackburn GM; Türkmen H
    Org Biomol Chem; 2005 Jan; 3(2):225-6. PubMed ID: 15632963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rosuvastatin: pharmacologic features].
    Bernini F; Catapano AL
    Ital Heart J; 2003 Dec; 4 Suppl 7():22S-32S. PubMed ID: 14983744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A one-step synthesis of 2,3-dihydro-4H-pyran-4-ones from 3-ethoxy alpha,beta-unsaturated lactones.
    Winkler JD; Oh K
    Org Lett; 2005 Jun; 7(12):2421-3. PubMed ID: 15932213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oppolzer sultam directed aldol as a key step for the stereoselective syntheses of antitumor antibiotic belactosin C and its synthetic congeners.
    Kumaraswamy G; Padmaja M; Markondaiah B; Jena N; Sridhar B; Kiran MU
    J Org Chem; 2006 Jan; 71(1):337-40. PubMed ID: 16388653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-catalyzed methylenation reaction: total synthesis of (+)-desoxygaliellalactone.
    Lebel H; Parmentier M
    Org Lett; 2007 Aug; 9(18):3563-6. PubMed ID: 17665920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro release of microparticles based on dextran-rosuvastatin conjugate.
    Zhou C; Gao W; Lu G; Ding J; Wu X; Huang X; Chen J; Liu M; Jiang J; Wu H
    Carbohydr Polym; 2013 Jul; 96(1):156-62. PubMed ID: 23688465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric synthesis of a chiral building block for cyclopentanoids: a novel enantioselective synthesis of preclavulone A.
    Zanoni G; Porta A; Brunoldi E; Vidari G
    J Org Chem; 2006 Oct; 71(22):8459-66. PubMed ID: 17064020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection.
    Hull CK; Martin PD; Warwick MJ; Thomas E
    J Pharm Biomed Anal; 2004 May; 35(3):609-14. PubMed ID: 15137986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding thermodynamics of statins to HMG-CoA reductase.
    Carbonell T; Freire E
    Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
    Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
    Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiospecific total synthesis of (-)-polyoxamic acid using 2,3-aziridino-gamma-lactone methodology.
    Tarrade A; Dauban P; Dodd RH
    J Org Chem; 2003 Nov; 68(24):9521-4. PubMed ID: 14629187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis of (-)-kainic acid via intramolecular Michael addition: a second-generation route.
    Sakaguchi H; Tokuyama H; Fukuyama T
    Org Lett; 2008 May; 10(9):1711-4. PubMed ID: 18402455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of rosuvastatin in urine by spectrofluorimetry after liquid-liquid extraction and derivatization in acidic medium.
    Braga VS; Mancilha TP; Cassella RJ; Pacheco WF
    J Fluoresc; 2013 Jan; 23(1):49-55. PubMed ID: 22903763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.